Evolent Health, Inc Class A Common Stock

Evolent Health, Inc Class A Common Stock

Compare this stock

EVH Stock Report Card

$

VolatilityTechnicalsProfitPerformanceEarningsAnalyst Price Targets

60%

Performance

Score:

80/100

EVH returned 17.00% in the last 12 months. Based on SPY's performance of 13.09%, its performance is above average giving it a score of 79 of 100.

Analyst Price Targets

Score:

88/100

13 analysts offer 12-month price targets for EVH. Together, they have an average target of 47.5, the most optimistic target put EVH at 50 within 12-months and the most pessimistic has EVH at 45.

Technicals

Score:

82/100

EVH receives a 82 of 100 based on 14 indicators. 11 are bullish, 2 are bearish.

Earnings

Score:

67/100

EVH has missed earnings 3 times in the last 20 quarters.

Profit

Score:

10/100

Out of the last 20 quarters, EVH has had 1 profitable quarters and has increased their profits year over year on 1 of them.

Volatility

Score:

46/100

EVH has had a lower than average amount of volatility over the last 12 months giving it a score of 45 of 100.

Evolent Health, Inc Class A Common Stock Summary

New York Stock Exchange / EVH
Healthcare
Medical - Healthcare Information Services
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.